References
- Green D, Lcchner K. A survey of 215 non-hemophilic palients with inhibitors to factor VIII. Thromb Haemosl. 1981; 45: 200–3
- Hultin M. Acquired inhibitors in malignant and nonmalignant disease states. Am J Med. 1991; 91 (Suppl 5a): 9S-13S.
- Hcrbst KD, Rapaport SI, Kenoyer DG et al. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone. Ann Intern Med. 1981;95:575–8.
- Green D. Cytotoxic suppression of acquired factor VIII: C inhibitors. Am J Med. 1991; 91 (Suppl5A): 14S-9S.
- Kunkel L. Acquired circulatory anticoagulants. Hemat Oncol Clin. 1992; 6: 1341–57.
- Green D. Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide. Blood. 1971; 37: 381–7.
- Sjamsoedin L, Heyncn L, Mauscr-Bunschoten E et al. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hacmophilia-A and antibodies to factor F VIII. N Engl J Med. 1981; 305: 717–21.
- Hedner U, Kisiel W. Use of human factor Villa in the treatment of two haemophilia A patients with high litre inhibitors. J Clin Invest. 1983; 71: 186341.
- Hay C, Laurian Y, Verroust Fct al. Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy. Blood. 1990; 76: 882–6.
- Sultan Y, Kazatchkine M, Nydcgger U ct al. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors. Am J Med. 1991; 91 (Suppl 5A): 35S-9S.